Clinical Trial

Pharmacogenomic Testing in Antidepressant Drug Therapy

Study Description

Pharmacogenomic Testing to Optimize Antidepressant Drug Therapy

A randomized controlled trial comparing pharmacogenomic guided versus standard pharmacist care to optimize antidepressant drug therapy. This study evaluates the effectiveness of pharmacists utilizing pharmacogenomic testing in the community pharmacy setting to help patients find the most appropriate drug therapy option(s) and minimize the risk of side effects in collaboration with prescribing physicians.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Pharmacogenomic Testing

pharmacogenomic drug response test provides personalized insights on a patient's predicted response to medications based on metabolism

Pharmacist Standard of Care

Pharmacist providing standard of care as per usual practice

Additional Information

Official Study Title

A Randomized Controlled Trial of Pharmacogenomic Guided Versus Standard Pharmacist Care to Optimize Antidepressant Drug Therapy in a Community Pharmacy Setting

Clinical Trial ID

NCT03591224

ParticipAid ID

egJJGd